Pulmonary diseases caused by non-tuberculous mycobacteria

Jakko van Ingen, David E. Griffith, Timothy Aksamit, Dirk Wagner

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pulmonary disease due to non-tuberculous mycobacteria (NTM) is an emerging infection, mainly in regions with a decreasing prevalence of tuberculosis (TB). Patients with existing pulmonary diseases (e.g. cystic fibrosis, chronic obstructive pulmonary disease (COPD) and/or bronchiectasis), or patients with local or systemic immunosuppression are at risk of developing NTM lung disease. Disease manifestations can be: fibrocavitary, resembling TB; nodular/bronchiectatic, usually in elderly lean, nonsmoking female patients; or hypersensitivitylike after exposure to contaminated water. Since the clinical relevance of pulmonary NTM isolates differs significantly between NTM species, correct laboratory identification of NTM isolates is important to guide treatment decisions and drug-susceptibility testing (DST) efforts. Diagnosis requires the application of clinical and microbiological criteria according to published American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. Treatment decisions need to be individualised; long-term antibiotic therapy may be combined with surgical resection of affected portions of the lung.

Original languageEnglish (US)
Pages (from-to)25-37
Number of pages13
JournalEuropean Respiratory Monograph
Volume58
DOIs
StatePublished - 2012

Fingerprint

Mycobacterium
Lung Diseases
Tuberculosis
Lung
Bronchiectasis
Cystic Fibrosis
Immunosuppression
Chronic Obstructive Pulmonary Disease
Therapeutics
Guidelines
Anti-Bacterial Agents
Water
Infection
Pharmaceutical Preparations

Keywords

  • Lung disease
  • Mycobacterium abscessus
  • Mycobacterium avium
  • Mycobacterium intracellulare
  • Mycobacterium xenopi
  • Non-tuberculous mycobacteria

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pulmonary diseases caused by non-tuberculous mycobacteria. / van Ingen, Jakko; Griffith, David E.; Aksamit, Timothy; Wagner, Dirk.

In: European Respiratory Monograph, Vol. 58, 2012, p. 25-37.

Research output: Contribution to journalArticle

van Ingen, Jakko ; Griffith, David E. ; Aksamit, Timothy ; Wagner, Dirk. / Pulmonary diseases caused by non-tuberculous mycobacteria. In: European Respiratory Monograph. 2012 ; Vol. 58. pp. 25-37.
@article{568d42cfd5f948929f601340aeab81e9,
title = "Pulmonary diseases caused by non-tuberculous mycobacteria",
abstract = "Pulmonary disease due to non-tuberculous mycobacteria (NTM) is an emerging infection, mainly in regions with a decreasing prevalence of tuberculosis (TB). Patients with existing pulmonary diseases (e.g. cystic fibrosis, chronic obstructive pulmonary disease (COPD) and/or bronchiectasis), or patients with local or systemic immunosuppression are at risk of developing NTM lung disease. Disease manifestations can be: fibrocavitary, resembling TB; nodular/bronchiectatic, usually in elderly lean, nonsmoking female patients; or hypersensitivitylike after exposure to contaminated water. Since the clinical relevance of pulmonary NTM isolates differs significantly between NTM species, correct laboratory identification of NTM isolates is important to guide treatment decisions and drug-susceptibility testing (DST) efforts. Diagnosis requires the application of clinical and microbiological criteria according to published American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. Treatment decisions need to be individualised; long-term antibiotic therapy may be combined with surgical resection of affected portions of the lung.",
keywords = "Lung disease, Mycobacterium abscessus, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium xenopi, Non-tuberculous mycobacteria",
author = "{van Ingen}, Jakko and Griffith, {David E.} and Timothy Aksamit and Dirk Wagner",
year = "2012",
doi = "10.1183/1025448x.10022511",
language = "English (US)",
volume = "58",
pages = "25--37",
journal = "European Respiratory Monograph",
issn = "1025-448X",
publisher = "European Respiratory Society",

}

TY - JOUR

T1 - Pulmonary diseases caused by non-tuberculous mycobacteria

AU - van Ingen, Jakko

AU - Griffith, David E.

AU - Aksamit, Timothy

AU - Wagner, Dirk

PY - 2012

Y1 - 2012

N2 - Pulmonary disease due to non-tuberculous mycobacteria (NTM) is an emerging infection, mainly in regions with a decreasing prevalence of tuberculosis (TB). Patients with existing pulmonary diseases (e.g. cystic fibrosis, chronic obstructive pulmonary disease (COPD) and/or bronchiectasis), or patients with local or systemic immunosuppression are at risk of developing NTM lung disease. Disease manifestations can be: fibrocavitary, resembling TB; nodular/bronchiectatic, usually in elderly lean, nonsmoking female patients; or hypersensitivitylike after exposure to contaminated water. Since the clinical relevance of pulmonary NTM isolates differs significantly between NTM species, correct laboratory identification of NTM isolates is important to guide treatment decisions and drug-susceptibility testing (DST) efforts. Diagnosis requires the application of clinical and microbiological criteria according to published American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. Treatment decisions need to be individualised; long-term antibiotic therapy may be combined with surgical resection of affected portions of the lung.

AB - Pulmonary disease due to non-tuberculous mycobacteria (NTM) is an emerging infection, mainly in regions with a decreasing prevalence of tuberculosis (TB). Patients with existing pulmonary diseases (e.g. cystic fibrosis, chronic obstructive pulmonary disease (COPD) and/or bronchiectasis), or patients with local or systemic immunosuppression are at risk of developing NTM lung disease. Disease manifestations can be: fibrocavitary, resembling TB; nodular/bronchiectatic, usually in elderly lean, nonsmoking female patients; or hypersensitivitylike after exposure to contaminated water. Since the clinical relevance of pulmonary NTM isolates differs significantly between NTM species, correct laboratory identification of NTM isolates is important to guide treatment decisions and drug-susceptibility testing (DST) efforts. Diagnosis requires the application of clinical and microbiological criteria according to published American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. Treatment decisions need to be individualised; long-term antibiotic therapy may be combined with surgical resection of affected portions of the lung.

KW - Lung disease

KW - Mycobacterium abscessus

KW - Mycobacterium avium

KW - Mycobacterium intracellulare

KW - Mycobacterium xenopi

KW - Non-tuberculous mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=84870844856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870844856&partnerID=8YFLogxK

U2 - 10.1183/1025448x.10022511

DO - 10.1183/1025448x.10022511

M3 - Article

AN - SCOPUS:84870844856

VL - 58

SP - 25

EP - 37

JO - European Respiratory Monograph

JF - European Respiratory Monograph

SN - 1025-448X

ER -